Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about clinical trial
Recent news which mentions clinical trial
Corbus Pharma (CRBP) Stock Drops 60% After Novo Nordisk's Cannabinoid-Based Weight Loss Drug Trial Disappoints
September 20, 2024
Tickers
CRBP
NEWS
NVO
Tags
News
Novo Nordisk
cannabis news
From
Benzinga
Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials
September 05, 2024
Tickers
CCC
DMT
GHRS
NEWS
Tags
Psychedelics
Benzinga
CCC
From
Benzinga
Autism CBD Trial On Children Advances As Israeli Company Enrolls First Five Patients
August 20, 2024
Tickers
CBD
CCC
NEWS
SPRC
Tags
News
Oz Adler
CBD
From
Benzinga
IVIEW Therapeutics Inc. Announces Dosing of First Patient in Phase 1/2 Clinical Trial of IVW-1001 for Dry Eye Disease
June 25, 2024
Tags
Dry Eye Disease
United States
Eyelid Wipe
From
PRLog
Federal Money To Support Research On Psychedelics As Alternative To Pills For Chronic Pain Among The Elderly
April 29, 2024
Tickers
NEWS
Tags
Health Care
Top Stories
News
From
Benzinga
Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments
March 08, 2024
Tickers
CBD
NEWS
SPRC
TKUNF
Tags
cannabis and autism
CBD
Oz Adler
From
Benzinga
Game Changing Move? NFL Tackles Pain And Concussions In CBD Clinical Trial Partnership With Canadian University
January 17, 2024
Tickers
CBD
NEWS
NFL
Tags
University of Regina
General
Benzinga
From
Benzinga
Awakn Life Sciences Enters Into Global Licensing Agreement For Sublingual Delivery Formulation
December 21, 2023
Tickers
AWKNF
Tags
contributors
AWKNF
Psychedelics
From
Benzinga
Expert Opinions on Dry Eye Treatment Innovations
July 13, 2023
Tags
New Jersey
Clinical Trial
Unmet Medical Need
From
PRLog
Cybin: Positive Clinical Trial On Psilocybin Analog For Major Depression & Updates On DMT Analog Program
March 02, 2023
Tickers
CYBN
Tags
Psychedelics
Benzinga
Psychedelic/Assisted Therapies
From
Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
December 27, 2022
Tickers
KONEF
NMLSF
Tags
Penny Stocks
Health Canada Approval
Cannabis
From
Benzinga
Veru Stock Could Retrace Week's 45% Gain As FDA Panel Votes Against COVID-19 Drug
November 10, 2022
Tickers
BIOVF
VERU
Tags
General
Small Cap
FDA
From
Benzinga
Atai Launches Phase 1 Clinical Trial On Novel Direct-To-Brain Drug Delivery Technology
October 18, 2022
Tickers
ATAI
Tags
clinical trial
Florian Brand
Markets
From
Benzinga
Cannabinoids & Autism Spectrum Disorder: This Baltimore Company Is On Track To Start Phase 2 Clinical Trial For New Treatment
October 07, 2022
Tickers
CBD
GCAN
Tags
Benzinga
cannabinoids
Autism
From
Benzinga
Canadian Psychedelics Company To Begin First Global DMT Clinical Trial For Stroke Treatment
September 08, 2022
Tickers
AGNPF
Tags
Global
clinical trial
DMT Analogue
From
Benzinga
Perth skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
June 15, 2022
Tags
Australia
NMSC therapy
Basal Cell Carcinoma
From
PRLog
Cannabis Goes Head-to-Head With Big Pharma In New Zelira Therapeutics Pain Med Study
June 09, 2022
Tickers
ZLDAF
Tags
Pain Medication
General
Startups
From
Benzinga
How To Enroll In A Psychedelic Clinical Trial In 5 Easy Steps
April 29, 2022
Tags
PTSD
anxiety
ADHD
From
Benzinga
Charlotte's Web: Positive Results In Clinical Trial Of Hemp-Derived CBD For Stress, Sleep And Well-Being
February 08, 2022
Tickers
CBD
CWBHF
CWEB
Tags
Small Business
Radicle ACES
Benzinga
From
Benzinga
MindMed Successfully Completes Phase 1 Trial Of 18-MC
January 19, 2022
Tickers
MNMD
Tags
psychedelics
Penny Stocks
contributors
From
Benzinga
Abbott Launches New Initiative to Drive Diversity in Medical Research and Improve Care Among Under-Represented Populations
November 03, 2021
Tickers
ABT
Tags
Diversity & Inclusion
Abbott
medical research
From
3BL Media: Corporate Social Responsibility, Energy and Health News
MindMed Leverages Ayahuasca's Ingredient DMT In Psychedelic-Inspired Therapies, Launches Trials With 30 Subjects
July 29, 2021
Tickers
MNMD
Tags
MNMD
Benzinga
Ayahuasca
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.